TREATMENT OF RECURRENT AND METASTATIC DISEASE

ESGO eAcademy, Ate van der Zee, 202749

CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR

ESGO eAcademy, Cristiana Sessa, 202754

CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR

ESGO eAcademy, Dominik Schneider, 202753

CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA

ESGO eAcademy, Philippe Morice, 202752

CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA

ESGO eAcademy, Gabriele Calaminus, 202751

DIAGNOSIS, STAGING AND PREOPERATIVE WORKUP

ESGO eAcademy, Maaike Oonk, 202747

Practical experiences from CTCA at Southeastern RegionalMedical Center, Georgia USA

ESGO eAcademy, Mansoor Raza Mirza, 202740

Pathological aspects of uterine carcinocarcoma

ESGO eAcademy, Mojgan Devouassoux, 202903

Practical experiences from Klinik für Gynäkologie, Die Charité – Universitätsmedizin Berlin, Germany

ESGO eAcademy, Jacek Grabowski, 202739

ROBOTIC EXPERT VIDEO

ESGO eAcademy, Rainer Kimmig, 261658

CONCLUSION

ESGO eAcademy, Andreas Du Bois, 202736

Q&A and Discussion

ESGO eAcademy, Session Speakers, 203120

SELECTING PATIENTS FOR PARP INHIBITION

ESGO eAcademy, Mansoor Mirza, 202735

RELAPSED OVARIAN CANCER: WHAT DOES MAINTENANCE THERAPY OFFER?

ESGO eAcademy, Nicoletta Colombo, 202733

Welcome and introduction

ESGO eAcademy, Christian Marth, 202732

QUESTIONS REMAINED TO BE ANSWERED

ESGO eAcademy, David Cibula, 202728

CIRCULATING TUMOR CELLS: CHALLENGES & PERSPECTIVES IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Catherine Alix-Panabieres, 202731

SLN IMPLEMENTATION INTO MANAGEMENT ALGORITHMS

ESGO eAcademy, Nadeem Abu Rustum, 202727

DETECTION OF METHYLATED DNA IN VARIOUS BODY FLUIDS AND THEIR USE AS DIAGNOSTIC, PROGNOSTIC AND PREDICTIVE TOOLS IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Heidi Fiegl, 202730

DEVELOPMENTS IN DETECTION TECHNIQUES

ESGO eAcademy, Eric Leblanc, 202726

WHOLE-GENOME SEQUENCING OF CELL-FREE DNA IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Adriaan Vanderstichele, 202729

Ultrasound Characteristics Of Endometrial Cancer As Defined By The International Endometrial Tumor Analysis (IETA) Consensus Nomenclature- A Prospective Multicenter Study

ESGO eAcademy, Daniela Fischerova, 202910

LION – LYMPHADENECTOMY IN OVARIAN NEOPLASMS. A PROSPECTIVE RANDOMIZED AGO STUDY GROUP LED GYNECOLOGIC CANCER INTERGROUP TRIAL.

ESGO eAcademy, Domenica Lorusso, 202722

UTERINE CORPUS

ESGO eAcademy, Sigurd Lax, 202725

WHAT MODIFIES THE OUTCOME OF RECURRENT GRANULOSA CELL TUMORS OF THE OVARY?

ESGO eAcademy, Isabel Carriles, 202721

OVARY AND FALLOPIAN TUBE

ESGO eAcademy, Matias-Guiu Guia, 202724

PRE-SURGICAL METFORMIN IN UTERINE MALIGNANCY-RESULTS OF THE PREMIUM RANDOMISED CONTROLLED TRIAL

ESGO eAcademy, Sarah Kitson, 202719

CERVIX, VULVA, VAGINA

ESGO eAcademy, Glenn McCluggage, 202723

Development And Pre-Testing Of The Eortc Quality Of Life Questionnaire For Vulva Cancer Patients – The Significance Of Patient Involvement

ESGO eAcademy, Pernille Jensen, 202909

Closing and remarks

ESGO eAcademy, Andreas Du Bois, 202716

Being Practical Case 3

ESGO eAcademy, Christian Marth, 202715

Being Practical Case 2

ESGO eAcademy, Nicoletta Colombo, 202714

Being Practical Case 1

ESGO eAcademy, Isabelle Ray-Coquard, 202713

SETTING THE SCENE: QUALITY OF LIFE IN OVARIAN CANCER, IS IT A KEY FACTOR FOR OUR DECISION MAKING?

ESGO eAcademy, Felix Hilpert, 202712

Introduction

ESGO eAcademy, Andreas Du Bois, 202711

Prognostic Factors For Local Recurrence Of Squamous Cell Carcinoma Of The Vulva: A Systematic Review

ESGO eAcademy, Nienke Te Grootenhuis, 202908

The New Normal; Sexual Function after Ovarian Cancer for Survivors and Partners Compared to Normdata

ESGO eAcademy, Maria Caroline Vos, 202907

HOW LONG SHOULD HORMONAL TREATMENT BE CONTINUED BEFORE DECIDING FOR HYSTERECTOMY IN THE FERTILITY SPARING MANAGEMENT OF ENDOMETRIAL CANCER?

ESGO eAcademy, Nicoletta Colombo, 202704

VULVA CANCER

ESGO eAcademy, Ate van der Zee, 202709

The Role Of The Peritoneal Cancer Index In Surgery For Advanced Ovarian Cancer

ESGO eAcademy, Mikkel Rosendahl, 202906

FERTILITY SPARING MANAGEMENT IN CERVICAL CANCERS BETWEEN 2 AND 4 CM: RADICAL TRACHELECTOMY BY LAPAROTOMY OR NEO-ADJUVANT CHEMOTHERAPY?

ESGO eAcademy, Ignace Vergote, 202703

OVARIAN CANCER

ESGO eAcademy, Christoph Grimm, 202708

The Peritoneal Cancer Index(PCI): Selted Regions - And Not The Total PCI - Are Predictive Of Survival In Advanced Ovarian Cancer

ESGO eAcademy, Mikkel Rosendahl, 202905

CAN WE SAFELY USE OVARIAN HYPERSTIMULATION IN INFERTILE PATIENTS AFTER FSS FOR EPITHELIAL TUMORS?

ESGO eAcademy, Dominik Denschlag, 202702

CERVICAL CANCER

ESGO eAcademy, Daniela Fischerova, 202707

FERTILITY SPARING MANAGEMENT IN HIGH RISK EPITHELIAL OVARIAN CANCER

ESGO eAcademy, Enrica Bentivegna, 202701

Imaging in the diagnosis and management of endometrial cancer

ESGO eAcademy, Ingfrid Haldorsen, 202706

CHANGES IN NEOANGIOGENETIC PROFILE OF PAIRED PRIMARY AND RECURRENT HIGH-GRADE SEROUS OVARIAN CANCER (HGOSC): A STUDY OF THE “OCTIPS” CONSORTIUM.

ESGO eAcademy, Ilary Ruscito, 202699

CISPLATIN CHEMO-RADIATION VERSUS RADIATION IN FIGO STAGE IIIB SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX (CRACX TRIAL: NCT00193791)

ESGO eAcademy, Umesh Mahantshetty, 202698

AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL WITH CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER: OVERALL SURVIVAL RESULTS

ESGO eAcademy, Isabelle Ray-Coquard, 202697

EMBRACE THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER

ESGO eAcademy, Tjalling Bosse, 202696

Randomized Controlled Phase III Study To Evaluate Secondary Cytoreductive Surgery In Platinum-Sensitive Recurrent Ovarian Cancer - AGO Desktop III/ENGOT Ov20

ESGO eAcademy, Jalid Sehouli, 202904

Medical treatment of uterine carcinosarcoma

ESGO eAcademy, Isabelle Ray-Coquard, 190586

Surgical treatment of serous endometrial cancer

ESGO eAcademy, Frederic Guyon, 190585

Long- term therapy with gonadoliberin analogues in patient with ovarian cancer.

ESGO eAcademy, Session Speakers, 191006

High grade serous ovarian cancer stage IV, multiple relapses

ESGO eAcademy, Session Speakers, 191003

Ovarian Cancer in Pregnancy

ESGO eAcademy, Session Speakers, 190595

Surgical treatment of low grade serous ovarian cancer

ESGO eAcademy, Jalid Sehouli, 180471

Medical Tumor Therapy for Germ Cell Tumors of Adults

ESGO eAcademy, Michael Seckl, 180466

Systemic treatment for low grade serous carcinoma

ESGO eAcademy, Michael Seckl, 180469

Surgical treatment for malignant germ cell tumor.

ESGO eAcademy, Pauline Wimberger, 180467

Pathologic aspects of Germ Cell Tumors

ESGO eAcademy, Doris Mayr, 180468

Pathologic aspects of Low Grade Serous Ovarian Cancer

ESGO eAcademy, Doris Mayr, 180470

Look into the future: Medical treatment of ovarian cancer in 2026

ESGO eAcademy, Ignace Vergote, 173572

Immunotherapy in gynecological malignancies

ESGO eAcademy, An Coosemans, 173570

Why do studies of targeted treatment fail?

ESGO eAcademy, Jonathan Ledermann, 173568

Targeting PARP: Mechanisms of action, available evidence, selection of patients, management of toxicities

ESGO eAcademy, Jonathan Ledermann, 173567

Targeting tyrosine kinases

ESGO eAcademy, Jonathan Ledermann, 173566

Molecular pathways in cervical cancer

ESGO eAcademy, Heidi Lyng, 173565

Molecular pathways in endometrial cancer

ESGO eAcademy, Henrica Maria Johanna Werner, 173564

Molecular pathways of low-grade ovarian cancer

ESGO eAcademy, Kristina Lindemann, 173563

Molecular pathways of high grade ovarian cancer

ESGO eAcademy, Adriaan Vanderstichele, 173562

Surgical aspects of uterine carcinosarcoma (~ serous)

ESGO eAcademy, Frederic Amant, 173558

Ultrasound guided procedures

ESGO eAcademy, Michal Zikan, 173920

Ovarian cancer staging

ESGO eAcademy, Daniela Fischerova, 173919

Endometrial cancer diagnosis and staging

ESGO eAcademy, Elisabeth Epstein, 173918

Cervical cancer staging

ESGO eAcademy, Antonia Testa, 173917

Abdominal scan

ESGO eAcademy, Daniela Fischerova, 173916

Pelvic imaging

ESGO eAcademy, Daniela Fischerova, 173915

Introduction

ESGO eAcademy, David Cibula, 173914

Uterine carcinosarcoma: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173556

Serous endometrial cancer: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173557

Serous endometrial cancer: current management and targeted therapies

ESGO eAcademy, Annamaria Ferrero, 173555

PMMR in endometrial cancer - Part one - Compartmental lymphatic network of uterine corpus and its drainage

ESGO eAcademy, Rainer Kimmig, 166631

PMMR in endometrial cancer - Part two - Surgical technique

ESGO eAcademy, Rainer Kimmig, 166632

Adjuvant Treatment and Place of Radiation Therapy in Vulvar Cancer

ESGO eAcademy, Carien Creutzberg, 150846

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

ESGO eAcademy, Mansoor Raza Mirza, 154789

New ESGO Guidelines of Management of Vulvar Cancer

ESGO eAcademy, Ate van der Zee, 150845

How to Stage Locally Advanced Cervical Cancer (Radiological and Surgical) before Chemoradiation Therapy

ESGO eAcademy, Sebastien Gouy, 150844

Management of the Clear Cell Ovarian Carcinoma

ESGO eAcademy, Keiichi Fujiwara, 150843

Phase 2: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Jonathan Ledermann, 150268

Surrogate Endpoints

ESGO eAcademy, Paolo Bruzzi, 150266

Phase 1/1B: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Cristiana Sessa, 150267

Statistical Plans, Interim Analysis and Subgroup Analysis

ESGO eAcademy, Paolo Bruzzi, 150265

Vulvar Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Fabio Landoni, 150264

Endometrial Cancer: What Do We Know? What Don't We Know ? What Should Be Investigated?

ESGO eAcademy, Eric Pujade-Lauraine, 150263

Uterine Sarcoma: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Andres Poveda, 150262

Cervical Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Christian Marth, 150261

Welcome & Introduction

ESGO eAcademy, Nicoletta Colombo, 150269

New Classification of Uterine Sarcoma

ESGO eAcademy, Sabrina Croce, 147380